Prometic Life Sciences Inc operates as a biopharmaceutical company with two drug discovery platforms that focuses on unmet medical needs in the field of fibrosis and orphan diseases. Its product pipeline includes PBI-4050, an orally active lead drug candidate for fibrosis; plasminogen, a biopharmaceutical for the treatment of congenital plasminogen deficiency; and intravenous immunoglobulin, a preparation of antibodies purified from plasma donations from healthy individuals.
Read More…
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone1-450-781-0115
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$36.55 million
Profitability
Miscellaneous
Employees487
Next Earnings Date8/13/2019 (Estimated)
OptionableNot Optionable
ProMetic Life Sciences (OTCMKTS:PFSCF) Frequently Asked Questions
What is ProMetic Life Sciences' stock symbol?
ProMetic Life Sciences trades on the OTCMKTS under the ticker symbol "PFSCF."
How were ProMetic Life Sciences' earnings last quarter?
ProMetic Life Sciences Inc. (OTCMKTS:PFSCF) issued its earnings results on Monday, April, 1st. The company reported $0.01 earnings per share for the quarter. The company earned $8.02 million during the quarter. ProMetic Life Sciences had a negative return on equity of 3,350.55% and a negative net margin of 373.05%. View ProMetic Life Sciences' Earnings History.
When is ProMetic Life Sciences' next earnings date?
What is the consensus analysts' recommendation for ProMetic Life Sciences?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ProMetic Life Sciences in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for ProMetic Life Sciences.
Has ProMetic Life Sciences been receiving favorable news coverage?
News coverage about PFSCF stock has trended somewhat positive recently, InfoTrie reports. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. ProMetic Life Sciences earned a media sentiment score of 1.5 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 8.0 out of 10, meaning that recent press coverage is very likely to have an effect on the stock's share price in the near future. View News Stories for ProMetic Life Sciences.
Who are some of ProMetic Life Sciences' key competitors?
Some companies that are related to ProMetic Life Sciences include NewLink Genetics (NLNK), Oramed Pharmaceuticals (ORMP), Eyenovia (EYEN), IMMUTEP LTD/S (IMMP), Medicure (MCUJF), Agile Therapeutics (AGRX), Aridis Pharmaceuticals (ARDS), IVERIC bio (ISEE), Ophthotech (OPHT), Aquinox Pharmaceuticals (AQXP), CTI BioPharma (CTIC), Moleculin Biotech (MBRX), Zafgen (ZFGN), Proteostasis Therapeutics (PTI) and IntelGenx Technologies (IGXT).
What other stocks do shareholders of ProMetic Life Sciences own?
Who are ProMetic Life Sciences' key executives?
ProMetic Life Sciences' management team includes the folowing people:
- Mr. Kenneth H. Galbraith, CEO & Director (Age 56)
- Mr. Bruce Pritchard, COO & Interim CFO
- Mr. Patrick Sartore, Chief Legal Officer & Corp. Sec.
- Mr. Bruce Wendel, Chief Bus. Devel. Officer (Age 65)
- Dr. John Moran, Chief Medical Officer (Age 73)
How do I buy shares of ProMetic Life Sciences?
Shares of PFSCF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is ProMetic Life Sciences' stock price today?
One share of PFSCF stock can currently be purchased for approximately $0.0208.
How big of a company is ProMetic Life Sciences?
What is ProMetic Life Sciences' official website?
How can I contact ProMetic Life Sciences?
ProMetic Life Sciences' mailing address is 440 Boulevard Armand-Frappier Suite 300, Laval A8, H7V 4B4. The company can be reached via phone at 1-450-781-0115 or via email at [email protected]
MarketBeat Community Rating for ProMetic Life Sciences (OTCMKTS PFSCF)
MarketBeat's community ratings are surveys of what our community members think about ProMetic Life Sciences and other stocks. Vote "Outperform" if you believe PFSCF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PFSCF will underperform the S&P 500 over the long term. You may vote once every thirty days.
